[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100574282":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":34,"collaborators":10,"id":36,"slug":10,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":39,"acronym":10,"eligibilityCriteria":40,"healthyVolunteers":37,"sex":41,"minAge":10,"maxAge":10,"enrollmentInfo":42,"targetDuration":45,"studyType":46,"phases":10,"briefSummary":47,"conditions":48,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":59},{"fullName":5,"class":6},"Kissei Pharmaceutical Co., Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"fostamatinib treatmented",null,[12],"Drug: fostamatinib",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DRUG","fostamatinib","oral administration",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Kazunori Abe, director","CONTACT","0356843575","rinsyousiken@pharm.kissei.co.jp",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":10,"geoPoint":10,"contacts":32},"Research site","RECRUITING","Tokyo and Japanese Other Cities","Japan","JP",[33],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"type":35,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100574282",false,"NCT06757257","Special Drug Use-results Survey for Long-term Use (Fostamatinib)","Inclusion Criteria:\n\n* Patients with chronic idiopathic thrombocytopenic purpura who are treatment with fostamatinib for the first time.","ALL",{"count":43,"type":44},149,"ESTIMATED","18 Months","OBSERVATIONAL","The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.",[49],"Chronic Idiopathic Thrombocytopenic Purpura","2024-12-26",{"date":52,"type":53},"2025-01-03","ACTUAL",{"date":55,"type":53},"2023-05-29",{"date":57,"type":44},"2028-09-30",{"name":5,"class":6},1]